NCT03242122CompletedNot Applicable
Evaluation of Carbohydrates
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Abbott Nutrition
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Blood glucose response curve
Study Overview
Brief Summary
The study is open-label with a randomized, cross-over design using standard Gl methodology.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Other
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subjects are males or non-pregnant females in good health.
- •Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion Criteria
- •Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
- •Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.
Arms & Interventions
CHO Control 1 Glucose
Active Comparator
25 g glucose
Intervention: CHO Control 1 and 2 Glucose (Other)
CHO Experimental 1 Slowly Digested
Experimental
25 g slowly-digested carbohydrate blend
Intervention: CHO Experimental 1 Slowly Digested (Other)
CHO Experimental 2 Digestion Resistant
Experimental
25 g digestion-resistant carbohydrate blend
Intervention: CHO Experimental 2 Digestion Resistant (Other)
CHO Experimental 3 Low Sugar
Experimental
25 g low sugar carbohydrate blend
Intervention: CHO Experimental 3 Low Sugar (Other)
CHO Experimental 4 Maltodextrin
Experimental
25 g maltodextrin
Intervention: CHO Experimental 4 Maltodextrin (Other)
CHO Control 2 Glucose
Active Comparator
25 g glucose
Intervention: CHO Control 1 and 2 Glucose (Other)
Outcomes
Primary Outcomes
Blood glucose response curve
Time Frame: 0 to 120 minutes
area under the curve (AUG)
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Evaluation of Carbohydrates - Glycemic IndexGlycemic IndexNCT03508154Abbott Nutrition10
Completed
Not Applicable
Gelesis Glycemic Index StudyPreDiabetesObesityDiabetesNCT03124134Gelesis, Inc.20
Completed
Not Applicable
Evaluation of Carbohydrates Part 2Gastro-Intestinal ToleranceNCT03293706Abbott Nutrition13
Withdrawn
Not Applicable
Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin MonotherapyDiabetes MellitusNCT01961388Bayer
Completed
Phase 1
Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 CapsuleHealthyNCT01555398Hanmi Pharmaceutical Company Limited48